CEMAD, Digestive System Disease Center, was created with the support of the Fondazione Roma.
In 2019, after just over two years of activity has established itself as a national reference point for the diagnosis and treatment of a large number of Digestive System Diseases, such as Chronic Intestinal Inflammatory Diseases, tumors, malformations, and degenerations that affect the digestive tract and related organs such as the liver, biliary tract and pancreas.
Also, a strong research center, among the main research activities developed at CEMAD, a national reference center for the treatment and diagnosis of diseases of the digestive system, there is the study of the intestinal microbiota and its modulation for therapeutic purposes.
The study of the composition of the intestinal microbiota is the basis of numerous research projects that have enabled the identification of particular “microbial signatures” in various pathologies, not only gastrointestinal, with implications for the identification of pathogenesis mechanisms and new “targeted” therapeutic strategies in the context of personalized medicine.
The center is also the promoter of numerous research projects on faecal microbiota transplantation (FMT) with various objectives including standardization and dissemination of the technique and expansion of current clinical indications.
Furthermore, CEMAD is also the reference center for Chronic Inflammatory Bowel Diseases (IBD). For the management of these pathologies, a personalized approach has been developed where the patient, in its entirety and complexity, is placed at the center and evaluated according to the needs by a multidisciplinary team of specialists. Among these, there are also nutritionists and psychologists who take charge of the patient by accompanying him on the long journey that characterizes complex chronic diseases such as IBD.
For more information please visit the website